PI(18:1(9Z)/20:3(8Z,11Z,14Z))

Term ID

CHEBI:88644

Synonyms

1-(9Z-Octadecenoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
1-Oleoyl-2-homo-g-linolenoyl-sn-glycero-3-phosphoinositol
1-Oleoyl-2-homo-gamma-linolenoyl-sn-glycero-3-phosphoinositol
[(2R)-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Phosphatidylinositol(18:1/20:3)
Phosphatidylinositol(18:1n9/20:3n6)
Phosphatidylinositol(18:1w9/20:3w6)
Phosphatidylinositol(38:4)
PI(18:1/20:3)
PI(18:1n9/20:3n6)
PI(18:1w9/20:3w6)
PI(38:4)
PIno(18:1/20:3)
PIno(18:1n9/20:3n6)
PIno(18:1w9/20:3w6)
PIno(38:4)

(all 16)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PI(18:1(9Z)/20:3(8Z,11Z,14Z))

Phenotype where environments contain PI(18:1(9Z)/20:3(8Z,11Z,14Z))

No data available

Phenotype modified by environments containing PI(18:1(9Z)/20:3(8Z,11Z,14Z))

Phenotype affecting PI(18:1(9Z)/20:3(8Z,11Z,14Z))

No data available

Human Disease Model